Treating anxiety and depression cuts mortality risk in patients with heart disease: study
Psychotherapy and antidepressant use may be cardioprotective effect, research shows.
Treating anxiety and depression in adults with coronary artery disease or heart failure can reduce ED visits, rehospitalisations and death from any cause, according to a study in the Journal of the American Heart Association.
US researchers from The Ohio State University Wexner Medical Center in Columbus conducted a population-based, retrospective study to examine the association between psychotherapy or antidepressant use and health service utilisation among 1563 patients (mean age 50) with coronary artery disease or heart failure and comorbid anxiety or depression.
